2011
DOI: 10.1253/circj.cj-10-0792
|View full text |Cite
|
Sign up to set email alerts
|

Reduction Aortoplasty for the Ascending Aortic Aneurysm With Aortic Valve Disease - Does Bicuspid Valve Matter? -

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
15
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 22 publications
1
15
0
Order By: Relevance
“…During our follow-up study, the mean expansion degree and rate of ascending aorta were 0.39 AE 0.26 cm and 1.3 AE 0.8 mm/year, respectively, in patients with aortic redilatation. The results are comparable with those of other studies [23][24][25][26]. Significant differences between the postoperative and follow-up ascending aortic diameters were found in BAV group (35.5 AE 4.6 mm vs 37.0 AE 5.0 mm; P ¼ 0.009), which suggested that the close connection between BAV and aortic dilatation may lead to those differences [27][28][29].…”
Section: Commentsupporting
confidence: 88%
“…During our follow-up study, the mean expansion degree and rate of ascending aorta were 0.39 AE 0.26 cm and 1.3 AE 0.8 mm/year, respectively, in patients with aortic redilatation. The results are comparable with those of other studies [23][24][25][26]. Significant differences between the postoperative and follow-up ascending aortic diameters were found in BAV group (35.5 AE 4.6 mm vs 37.0 AE 5.0 mm; P ¼ 0.009), which suggested that the close connection between BAV and aortic dilatation may lead to those differences [27][28][29].…”
Section: Commentsupporting
confidence: 88%
“…34 Hwang et al reported reduction aortoplasty without aortic wrapping and acceptable long-term outcomes. 35 …”
Section: Choi Ms Et Almentioning
confidence: 99%
“…Given the statistically significant difference in distribution of age, sex, hypertension, and diabetes between BAV and TAV patients, all the analyses have been repeated after including only studies enrolling patients comparable for all these variables . Interestingly, the difference in prevalence of CAD (OR, 0.65; 95% CI, 0.33, 1.26; P =0.20) and mortality rate (OR, 1.77; 95% CI, 0.81, 3.87; P =0.15) were no longer significant.…”
Section: Resultsmentioning
confidence: 99%